Erin Colgan - Net Worth and Insider Trading

Erin Colgan Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Erin Colgan owns 1 companies in total, including Sensei Biotherapeutics Inc (SNSE) .

Click here to see the complete history of Erin Colgan’s form 4 insider trades.

Insider Ownership Summary of Erin Colgan

Ticker	Comapny	Transaction Date	Type of Owner
SNSE	Sensei Biotherapeutics Inc	2021-02-03	SVP of Finance

Erin Colgan Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Erin Colgan Ownership Network

Ownership Network List of Erin Colgan

No Data

Ownership Network Relation of Erin Colgan

Erin Colgan Owned Company Details

What does Sensei Biotherapeutics Inc do?

Who are the key executives at Sensei Biotherapeutics Inc?

Erin Colgan is the SVP of Finance of Sensei Biotherapeutics Inc. Other key executives at Sensei Biotherapeutics Inc include Chief Business Officer Stephanie Krebs , director & President & CEO John Celebi , and 10 percent owner & other: See Remarks Cambrian Biopharma Inc .

Sensei Biotherapeutics Inc (SNSE) Insider Trades Summary

Over the past 18 months, Erin Colgan made no insider transaction in Sensei Biotherapeutics Inc (SNSE). Other recent insider transactions involving Sensei Biotherapeutics Inc (SNSE) include a net sale of 3,441,661 shares made by Apeiron Investment Group Ltd. , and a net purchase of 500 shares made by John Celebi .

In summary, during the past 3 months, insiders sold 0 shares of Sensei Biotherapeutics Inc (SNSE) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 3,441,661 shares of Sensei Biotherapeutics Inc (SNSE) were sold and 500 shares were bought by its insiders, resulting in a net sale of 3,441,161 shares.

Sensei Biotherapeutics Inc (SNSE)'s detailed insider trading history can be found in Insider Trading Tracker table.

Sensei Biotherapeutics Inc Insider Transactions

No Available Data

Erin Colgan Mailing Address

Above is the net worth, insider trading, and ownership report for Erin Colgan. You might contact Erin Colgan via mailing address: C/o Sensei Biotherapeutcs, Inc., 1405 Research Blvd., Ste. 125, Rockville Md 20850.

Research Tools

All-In-One Screener Stock Ideas Stock List Guru List Guru Real-Time Picks Insider List Insider Trades Economic Indicators Sector & Industry Performance DCF Calculator Discussion Board

Product

Pricing Plans Excel Add-In Google Sheets Add-on Data API Stock Comparison Table Manual of Stocks Instant Alerts Mobile App 中文

Education

Financial Glossary Tutorials FAQ Schedule Free Session Buffett Indicator Shiller P/E Yield Curve Today U.S. Inflation Rate Global Market Valuation Fed Net Liquidity Buffett Assets Allocation

Company

About GuruFocus Career Contact Us Advertise Site Map Term of Use Privacy Policy Referral Program Partner Program

Survey

We'd love to learn more about your experiences on GuruFocus.com and how we can improve!

Take Survey

Disclaimers

GuruFocus.com is not operated by a broker or a dealer. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The individuals or entities selected as "gurus" may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. Gurus may be added or dropped from the GuruFocus site at any time. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes are provided by QuoteMedia, Inc. (CSI). Company fundamental data is provided by Morningstar. Analyst estimates data is sourced from both Refinitiv and Morningstar, with priority given to Refinitiv data. Data is updated daily.